This explainer is for police officers, firefighters, and EMS crews who are looking into care for depression that standard medication has not shifted, and who need to understand how each kind of care would fit around a shift schedule. It covers three models: treatment at a clinic, treatment at home, and a mix of the two.
Start with the right vocabulary
"Ketamine therapy" is a loose label for several different things. Knowing which is which will save you time and protect your safety.
- Esketamine (Spravato): A nose spray the FDA approved for grown patients whose depression is treatment-resistant (two or more antidepressants have not helped enough) and for grown patients with major depression plus acute suicidal thinking or behavior. Given in certified centers, nowhere else.
- IV ketamine: An anesthetic, approved for surgery, used off-label for depression by infusion at specialty clinics.
- At-home ketamine: Compounded tablets or lozenges from a telehealth prescriber, swallowed or dissolved at home with no clinician present. Also off-label for depression, and the subject of FDA warnings.
Few people know these distinctions. Our publisher's survey of 443 Midwest adults found the name Spravato unfamiliar to 73 percent. Figures in this piece come from the survey's validated final results. For a plain description of the approved option, see Brain Recovery Centers' page on Spravato treatment.
What people said they would prefer
The same survey asked how people would want to receive this kind of treatment. The largest group, 44 percent, chose an in-person clinic near them. A begin-at-the-clinic, finish-at-home plan was the pick of 23 percent; telehealth from home, 22 percent; the leftover 11 percent had no preference. First responders made up 4 percent of the sample; even counted with veterans they total only 29 people, too few to break out, so treat these as general preferences rather than a read on your profession.
Model one: clinic-based treatment
How it works. For esketamine, you use the spray under the eyes of a health care worker, then remain for two hours or more while staff check your blood pressure and watch for side effects like drowsiness, dizziness, or a detached, dreamlike feeling. The usual rhythm: twice weekly for the first four weeks or so, once weekly for roughly four more, and then weekly or every other week.
The rule that matters for your job. After a session you are barred from driving, and from anything needing full alertness, until the following day once you have slept. On the job side, that means no driving home, and no going on duty in a safety-sensitive role that same day.
Fitting it to shifts.
- 24-on, 48-off: Sessions can often land on the first day off, after you have slept following the shift, with the second off day for recovery.
- Rotating 12s: Aim for sessions at the start of a block of days off, not the evening before a shift.
- Straight nights: Ask centers about late-morning or early afternoon slots so you can sleep before and after.
These are planning ideas, not medical guidance. Your clinician will tell you how much recovery time you need based on how you respond.
Model two: at-home treatment
How it works. A telehealth prescriber evaluates you by video and ships ketamine to your home. You take it on a schedule set by the program, sometimes with another adult asked to be present.
Why it appeals. No drive, no waiting room, and more control over timing. For someone who worries about being seen at a clinic, privacy is a real draw.
What to weigh. It is not FDA-approved for depression. No clinician is physically present while the drug takes effect. And if your job involves firearms, emergency vehicles, or critical decisions, you need a clear, clinician-backed plan for when it is safe to return to duty. Any at-home program should be able to answer that in writing.
Model three: hybrid care
How it works. Because esketamine is never taken home, hybrid care usually means supervised treatment at a clinic combined with telehealth visits for check-ins, medication management, and therapy. You still go in for the treatment itself, but fewer total trips are required.
Why it can fit shift work. Video follow-ups can happen from the station on a slow day, or from home between shifts, which leaves in-person time for the sessions that require it.
Privacy and your department
Across the survey sample, 11 percent put "private and discreet" among the two things they most wanted from a provider, and 10 percent chose a provider specializing in veterans and first responders. For many in public safety, confidentiality weighs more than those numbers suggest. Practical steps:
- Ask any clinic who would be notified about your treatment. The answer should be no one, without your permission, in most situations.
- If you use an employee assistance program or peer support team, ask how confidentiality is handled before sharing details.
- Ask your clinician whether any medication or treatment triggers a disclosure or fitness-for-duty requirement in your role.
Paying for it
No factor in the survey beat coverage, which 85 percent placed in their top two. If you have department health insurance, ask the plan's member line if esketamine is covered and if you will need prior authorization. Off-label IV and at-home ketamine are usually cash-pay. If you are a veteran or military retiree, ask whether TRICARE applies to you.
Who to talk to first
Of everyone surveyed, 74 percent said they would try it on the advice of the physician they already see. Start there, or with a mental health provider you trust. Bring your medication history, your shift pattern, and your questions about duty. Whether any model fits you is a clinical decision that depends on your health and your job.
If the job has followed you home as thoughts of ending your life, reach out now. Dial 988 or text it, and if you served, press 1 when the call connects. That line is the Suicide and Crisis Lifeline; somebody answers every hour of every day.
Methodology
We report top-line numbers from a survey our publisher commissioned and paid for. Its home was Pollfish's consumer panel; responses stopped on June 23, 2026, at 443, each from someone between 18 and 64 living in Illinois, Kansas, Minnesota, Indiana, Oklahoma, Iowa, Ohio, Missouri, Nebraska, and Wisconsin. First responders are too scarce in the sample for their own figures. Pollfish finished validating the panel, so each figure is final.